Email ID
Password
Scrip   
Biovitrum's refocusing may tempt big pharma interest
17 February 2009
Simon Varcoe

Biovitrum's move away from primary care drugs to specialty care is almost complete, it told Scrip.

The Swedish company has cut around 200 jobs since announcing the restructuring in early 2008 and last month spun out its small molecule business into its UK-based R&D...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36